Enhancing Patient Safety: Addressing the Potentially Fatal Consequences of Undetected Hemolysis at the Point of Care
Tracking # 20-1342720
Price not reported
Course overview
Join us for an insightful webinar exploring patient safety risks and potentially fatal outcomes, due to undetected hemolysis at the point of care (POC). This webinar will cover patient cases where undetected hemolysis caused adverse patient outcomes, and will highlight how undetected hemolysis is exacerbated by insufficient awareness of blood gas testing limitations related to hemolysis. The importance of adopting solutions with integrated hemolysis detection to prevent these potential high-risk situations will be emphasized. Through expert-led discussions and actionable frameworks, attendees will learn how to adopt and scale technologies that drive efficiency across diverse hospital environments. Whether you're navigating resource constraints or planning future growth, this session offers practical guidance to strengthen your lab's impact and resilience.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Nam Tran, PhD, HCLD (ABB), FADLM
- Honorarium: Nova Biomedical, Thermo, Diasorin
- Consulting Fees: Roche, Radiometer
- Committee and/or Advisory Board: ADLM Board of Directors
- Alan Wu, PhD, DABCC
- Honorarium: Werfen
- Consulting Fees: Werfen
- Committee and/or Advisory Board: Werfen Advisory Board
The following faculty reported no financial relationships:
- Robert Cooper, MD, MBA, MPH